SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
SciClone Pharmaceuticals (Holdings) Ltd
Net Income (Common)
SciClone Pharmaceuticals (Holdings) Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
|
Net Income (Common)
¥1.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Net Income (Common)
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Net Income (Common)
¥2.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Net Income (Common)
¥4.2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Net Income (Common)
¥4.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Net Income (Common)
¥755.6m
|
CAGR 3-Years
36%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
See Also
What is SciClone Pharmaceuticals (Holdings) Ltd's Net Income (Common)?
Net Income (Common)
1.1B
CNY
Based on the financial report for Dec 31, 2023, SciClone Pharmaceuticals (Holdings) Ltd's Net Income (Common) amounts to 1.1B CNY.
What is SciClone Pharmaceuticals (Holdings) Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
16%
Over the last year, the Net Income (Common) growth was 31%. The average annual Net Income (Common) growth rates for SciClone Pharmaceuticals (Holdings) Ltd have been 14% over the past three years , 16% over the past five years .